| Cerebral Substrates of Prospective Memory in Young and Its Disruption in Normal Aging and in Alzheimer's Disease: A Study in Anatomical MRI, Diffusion Tensor MRI and Functional MRI (NCT02522091) | University Hospital, Caen | 2010-11-01 |
| Safety and Tolerability of AFFITOPE AD03 (NCT01309763) | Affiris AG | 2010-10-01 |
| Evaluation of a Diet in Patients With Senile Dementia (NCT01192529) | Vegenat, S.A. | 2010-10-01 |
| New Biomarker for Alzheimer's Disease Diagnostic (NCT01315639) | Assistance Publique - Hôpitaux de Paris | 2010-09-03 |
| Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease (NCT01117818) | Affiris AG | 2010-09-01 |
| AD01 Follow up Extension Visit (NCT01225809) | Affiris AG | 2010-09-01 |
| Study Evaluating The Safety Of AAB-003 (PF-05236812) In Subjects With Alzheimer's Disease (NCT01193608) | Pfizer | 2010-09-01 |
| Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease (NCT01058941) | Oregon Health and Science University | 2010-09-01 |
| The Swedish BioFINDER Study (NCT01208675) | Skane University Hospital | 2010-09-01 |
| Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease (NCT01254448) | Targacept Inc. | 2010-09-01 |
| Collaboration Between Department of Old Age Psychiatry and Nursing Homes (NCT01217541) | Sykehuset Innlandet HF | 2010-09-01 |
| Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of CHF5074 in Healthy Young Male Subjects (NCT01203384) | CERESPIR | 2010-09-01 |
| Deep Transcranial Magnetic Stimulation for Treatment of Alzheimer's Disease (NCT01179373) | Brainsway | 2010-08-01 |
| A Biomarker Study of Solanezumab in Patients With and Without Alzheimer's (NCT01148498) | Eli Lilly and Company | 2010-08-01 |
| A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study (NCT01230853) | Eisai Inc. | 2010-08-01 |
| Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease (NCT02035982) | Sunnybrook Health Sciences Centre | 2010-07-01 |
| Acute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's Disease (NCT01082965) | Pfizer | 2010-07-01 |
| Alzheimer's Disease Multiple Intervention Trial (NCT01314950) | Indiana University | 2010-07-01 |
| Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease- (NCT01129596) | Eisai Co., Ltd. | 2010-06-10 |
| Effects of Simvastatin on Biomarkers (NCT01142336) | University of Washington | 2010-06-01 |
| Apathy in Dementia Methylphenidate Trial (ADMET) (NCT01117181) | Johns Hopkins Bloomberg School of Public Health | 2010-06-01 |
| A Safety Study of LY2886721 Single Doses in Healthy Subjects (NCT01133405) | Eli Lilly and Company | 2010-06-01 |
| To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease (NCT01125683) | AstraZeneca | 2010-06-01 |
| Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient (NCT01424436) | GlaxoSmithKline | 2010-05-19 |
| Multiple Intravenous Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's Disease (NCT01125631) | Pfizer | 2010-05-01 |
| Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease (NCT01137526) | AbbVie (prior sponsor, Abbott) | 2010-05-01 |
| Dose Response Study of Aerobic Exercise in Older Adults (NCT01129115) | Jeff Burns, MD | 2010-05-01 |
| Effects of Exercise Training in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease (NCT02119546) | National Taiwan University Hospital | 2010-05-01 |
| Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD) (NCT01128361) | Jeff Burns, MD | 2010-05-01 |
| A Confirmatory Trial of SK-PC-B70M in Mild to Moderate Alzheimer's Disease (NCT01249196) | SK Chemicals Co., Ltd. | 2010-05-01 |
| An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease (NCT01066546) | Pfizer | 2010-04-01 |
| Alzheimer's Disease Neuroimaging Initiative Grand Opportunity (NCT01078636) | Alzheimer's Disease Cooperative Study (ADCS) | 2010-04-01 |
| A Study Of Oral PF-01913539 In Patients With Mild To Moderate Alzheimer's Disease (NCT01066481) | Pfizer | 2010-04-01 |
| Observational Study to Monitor Long-term Immunogenicity and Efficacy of UB 311 Vaccine in Subjects With Alzheimer's Disease (NCT01189084) | United Biomedical | 2010-04-01 |
| A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease (NCT01047579) | Novartis Pharmaceuticals | 2010-04-01 |
| Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease (NCT01073228) | FORUM Pharmaceuticals Inc | 2010-04-01 |
| An Extension of the CONCERT Protocol (DIM18) (NCT01152216) | Medivation, Inc. | 2010-04-01 |
| Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163 (NCT01079819) | Bristol-Myers Squibb | 2010-04-01 |
| Impact of Controlling Vascular Risk Factors on the Progression of Alzheimer's Disease (NCT01423396) | University Hospital, Lille | 2010-03-15 |
| Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers (NCT01005862) | Pfizer | 2010-03-01 |
| Thalidomide for Patients With Mild to Moderate Alzheimer's Disease (NCT01094340) | Banner Health | 2010-03-01 |
| Multiple Dose Study of TRx0037 (NCT01253499) | TauRx Therapeutics Ltd | 2010-03-01 |
| Trazodone for Sleep Disorders in Alzheimer's Disease (NCT01142258) | Brasilia University Hospital | 2010-03-01 |
| Evaluation of PET Scan Timing Relative to AV-45 Injection Time (NCT01565356) | Avid Radiopharmaceuticals | 2010-03-01 |
| Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients (NCT01097096) | Novartis Pharmaceuticals | 2010-03-01 |
| Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07 (NCT01447719) | Avid Radiopharmaceuticals | 2010-03-01 |
| Prazosin Treatment for Disruptive Agitation in Alzheimer's Disease (NCT01126099) | Seattle Institute for Biomedical and Clinical Research | 2010-03-01 |
| A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET) (NCT01503944) | Avid Radiopharmaceuticals | 2010-03-01 |
| Non Pharmacological Treatment in Alzheimer's Disease and Associated Disorders (NCT01143350) | Centre Hospitalier Universitaire de Nice | 2010-03-01 |
| Comparative Bioavailability in Healthy Elderly Volunteers (NCT01253122) | TauRx Therapeutics Ltd | 2010-02-01 |
| To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden (NCT00991419) | AstraZeneca | 2010-02-01 |
| Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease (NCT01716637) | Life Extension Foundation Inc. | 2010-02-01 |
| Study of the Pharmacokinetics and Pharmacodynamics of POSIPHEN® in Subjects With Amnestic Mild Cognitive Impairment (NCT01072812) | Annovis Bio Inc. | 2010-02-01 |
| A Randomized, Double-blind, Placebo-controlled, Sequential Ascending, Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2212 in Healthy Subjects (NCT01221259) | Eisai Inc. | 2010-01-01 |
| Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls (NCT01147679) | University of California, Los Angeles | 2010-01-01 |
| Alzheimer's Disease Reminiscence Quality of Life (NCT01295957) | Universidad Nacional de Rosario | 2010-01-01 |
| Multi-modality MRI Study on Prediction for Mild Cognitive Impairment Conversion (NCT02353884) | XuanwuH 2 | 2010-01-01 |
| A Study of Acupuncture for Patients With Behavioural and Psychological Symptoms of Dementia (NCT01055561) | Chengdu University of Traditional Chinese Medicine | 2010-01-01 |
| Multistimulation Group Therapy for Alzheimer's Disease (NCT01893398) | Fondazione Don Carlo Gnocchi ETS | 2010-01-01 |
| Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease (NCT01019421) | H. Lundbeck A/S | 2009-12-01 |
| Assess the Prognostic Usefulness of Flutemetamol (18F) Injection for Identifying Subjects With Amnestic Mild Cognitive Impairment Who Will Convert to Clinically Probable Alzheimer's Disease (NCT01028053) | GE Healthcare | 2009-12-01 |
| A Study of Semagacestat for Alzheimer's Patients (NCT01035138) | Eli Lilly and Company | 2009-12-01 |
| Effects of Exercise and Cognitive Training on Cognitive Function in Older Adults (NCT01038726) | The Cleveland Clinic | 2009-12-01 |
| Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease (NCT01018875) | AbbVie (prior sponsor, Abbott) | 2009-12-01 |
| The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil (NCT01024660) | AstraZeneca | 2009-12-01 |
| A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease (NCT01028911) | Pfizer | 2009-12-01 |
| Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease (NCT01009255) | GlaxoSmithKline | 2009-11-02 |
| Cytokines and Cognitive Decline in Alzheimer's Disease (NCT01351142) | Poitiers University Hospital | 2009-11-01 |
| Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly (NCT00811122) | University of Utah | 2009-11-01 |
| Phase II Study for Amyloid Binding Imaging Study of [18F]AV-45 in Patients With Mild Cognitive Impairment, Alzheimer's Disease and Healthy Volunteers (NCT01238458) | Chang Gung Memorial Hospital | 2009-11-01 |
| Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease (NCT01099332) | Adeona Pharmaceuticals | 2009-11-01 |
| Alzheimer's Disease and Related Disorders (NCT01315704) | University Hospital, Angers | 2009-11-01 |
| A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease (NCT00988598) | Pfizer | 2009-10-26 |
| Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 (NCT01093664) | Affiris AG | 2009-10-01 |
| A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) (NCT00988624) | Pfizer | 2009-10-01 |
| Genes, Exercise, Memory and Neurodegeneration (NCT01021644) | Howard University | 2009-10-01 |
| A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin (NCT00990613) | Pfizer | 2009-10-01 |
| Effect of Aricept on Biomarkers (Acetylcholine, sAPP Alpha) In Cerebrospinal Fluid (NCT00987220) | Pfizer | 2009-10-01 |
| Safety, Pharmacokinetics and Pharmacodynamics Study of Treatment With CHF 5074 in Healthy Young Male Subjects (NCT00954252) | CERESPIR | 2009-10-01 |
| A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users (NCT00975481) | Pfizer | 2009-10-01 |
| Early-onset and Late-onset Sporadic Alzheimer's Disease (AD) (NCT00987090) | Assistance Publique Hopitaux De Marseille | 2009-10-01 |
| Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease (NCT00951834) | Charite University, Berlin, Germany | 2009-10-01 |
| A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease (NCT00930059) | Pfizer | 2009-09-10 |
| Efficacy and Safety of Lornoxicam in Patients With Mild to Moderate Probable Alzheimer´s Disease. (NCT01117948) | JSW Lifesciences | 2009-09-01 |
| Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor (NCT00940589) | Neurim Pharmaceuticals Ltd. | 2009-09-01 |
| Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG) (NCT00973518) | Orasi Medical, Inc. | 2009-09-01 |
| An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease (NCT00939783) | Pfizer | 2009-09-01 |
| Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. (NCT01890343) | Avid Radiopharmaceuticals | 2009-09-01 |
| A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease (NCT00945672) | Pfizer | 2009-08-06 |
| Safety, Tolerability, And Immunogenicity Study Of ACC-001 In Japanese Subjects With Mild To Moderate Alzheimer's Disease (NCT00959192) | Pfizer | 2009-08-01 |
| Amyloid Plaque and Tangle Imaging in Alzheimer's Disease and Down Syndrome (NCT00965835) | National Institute on Aging (NIA) | 2009-08-01 |
| Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001) (NCT00954538) | Merck Sharp & Dohme LLC | 2009-08-01 |
| Exploratory and Safety Study of [F-18]W372 (NCT00954369) | Siemens Molecular Imaging | 2009-08-01 |
| The Effect of JNJ-39393406 on Event Related Potentials in Stable Schizophrenic Patients (NCT01137799) | Janssen Pharmaceutica N.V., Belgium | 2009-08-01 |
| Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease (NCT00955422) | National Institute of Mental Health (NIMH) | 2009-07-31 |
| Citalopram for Agitation in Alzheimer's Disease (NCT00898807) | JHSPH Center for Clinical Trials | 2009-07-01 |
| Rajavtihi Neuronal Adult Stem Cells Project (NCT00927108) | Department of Medical Services Ministry of Public Health of Thailand | 2009-07-01 |
| Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 (NCT00948766) | Novartis | 2009-07-01 |
| Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease (NCT00933608) | NYU Langone Health | 2009-07-01 |
| Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders (NCT01316562) | University Hospital, Angers | 2009-07-01 |